Prograf Capsule, Gelatin Coated
Product Images NDC 0469-0607

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Prograf (NDC 0469-0607). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Prograf 1 mg oral gelatin-coated capsules package label, featuring the brand and generic name Tacrolimus. The label indicates the dosage form as capsules and the labeler as Astellas Pharma US, Inc. The image includes printed text with dosage strength and identifying information primarily in English.*

FDA Label Image

Image 02

Prograf 5 mg gelatin-coated capsules in a blister pack. The capsules are red and white. The label shows the brand name Prograf and the active ingredient Tacrolimus. The packaging is from Astellas Pharma US, Inc., indicating an oral dosage form for prescription use.*

FDA Label Image

Image 03

Prograf Tacrolimus 1 mg gelatin coated oral capsules packaging. The box is labeled with the drug name, strength of 1 mg per capsule, and indicates it is a human prescription drug. The manufacturer is Astellas Pharma US, Inc. The packaging is primarily white with blue and pink accents.*

FDA Label Image

Image 04

Chemical structure of tacrolimus, the active ingredient in Prograf, shown with atomic bonds and molecular groups. The diagram includes ring formations, hydroxyl groups, and a water molecule (H2O) attached, illustrating the compound's molecular configuration.*

FDA Label Image

Image 05

FDA Label Image

Image 06

FDA Label Image

Image 07

Chemical structure of tacrolimus, the active ingredient in Prograf. The diagram depicts the molecular arrangement and connectivity of atoms within the tacrolimus compound.*

FDA Label Image

Image 08

Illustration depicting a preparation setup for Prograf granules, including a container with drinking water, a glass cup, a measuring device, scissors, a metal stirring spoon, and a paper towel, alongside a labeled carton of Prograf packets on a flat surface.*

FDA Label Image

Image 09

Illustration showing an open box labeled Prograf Granules (tacrolimus for oral suspension) with a hand pulling out a single blister strip from the box. The box displays the product name, usage form as oral suspension granules, and the labeler Astellas Pharma US, Inc.*

FDA Label Image

Image 10

An instructional illustration showing a hand holding scissors cutting open a sachet labeled Prograf Granules 0.2 mg per packet, with the Astellas Pharma logo visible on the packaging.*

FDA Label Image

Image 11

An instructional illustration showing a hand pouring granules from a small packet labeled Prograf into an open container. The image likely demonstrates the preparation or administration of Prograf (Tacrolimus) oral dosage form.*

FDA Label Image

Image 12

An instructional illustration showing a hand holding a spoon above a cup with powder inside. This likely demonstrates mixing medication powder with liquid, relevant for oral administration.*

FDA Label Image

Image 13

An instructional line drawing showing a hand stirring a glass of liquid with a spoon. The image uses arrows to indicate a circular stirring motion inside the glass. There is no text, branding, or product-specific detail visible in the image.*

FDA Label Image

Image 14

An illustration depicting a child drinking from a cup while being closely attended to by an adult woman, suggesting caregiving or medication administration support.*

FDA Label Image

Image 15

An instructional diagram shows items for administering Prograf Granules including a carton of Prograf Granules packets, a glass cup, a container with drinking water, an oral syringe with plunger, a metal stirring spoon, scissors, a measuring device, and a paper towel, all arranged on a surface.*

FDA Label Image

Image 16

Illustration showing an open box of Prograf Granules (tacrolimus for oral suspension) with a hand pulling out a single unit-dose packet from the blister-lined packaging. The image highlights the contents and dispensing form of the granules product by Astellas Pharma US, Inc.*

FDA Label Image

Image 17

An instructional illustration showing scissors cutting a sealed package labeled 'Prograf Granules 0.2 mg per single-dose packet' with the Astellas logo visible. The image demonstrates how to open a single-dose packet of Prograf granules.*

FDA Label Image

Image 18

An instructional illustration showing a hand pouring granular contents from a small packet labeled "Prograf" into an open cup. The illustration depicts particles falling from the packet into the cup, indicating a method of administering or preparing the Tacrolimus capsules for oral use.*

FDA Label Image

Image 19

An instructional line drawing illustrating a hand holding a spoon above a cup containing granular or powdered material, with some powder shown falling from the spoon into the cup. No text or branding is visible in the image.*

FDA Label Image

Image 20

An instructional illustration showing a hand holding a spoon stirring a glass cup containing a liquid with small particles. The arrows indicate a circular stirring motion in the liquid.*

FDA Label Image

Image 21

An instructional illustration showing a hand holding a tube-like device with a plunger, being submerged into a glass of liquid. The tube contains small round beads. This likely demonstrates a preparation or administration step for the medication Prograf (tacrolimus) capsules.*

FDA Label Image

Image 22

An instructional black-and-white line drawing showing an adult hand administering oral medication to an infant using an oral syringe placed inside the infant's mouth.*

FDA Label Image

Image 23

Packaging label for Prograf 0.5 mg capsules containing tacrolimus, USP. The label shows a package of 100 gelatin-coated oral capsules by Astellas Pharma US, Inc. The label includes storage instructions and mentions the product is manufactured by Astellas Ireland Co., Ltd. The label displays the NDC number 0469-0607-73 and features the Astellas logo.*

FDA Label Image

Image 24

The image shows a unfolded carton label for Prograf 1 mg capsules, a gelatin-coated oral drug containing tacrolimus. The label indicates 100 capsules per container, with storage instructions and mentions it is manufactured by Astellas Ireland Co., Ltd. and marketed by Astellas Pharma US, Inc. The design includes the Prograf name, dosage strength, and the Astellas logo prominently displayed.*

FDA Label Image

Image 25

Packaging label for Prograf (tacrolimus) capsules, USP, 5 mg strength. The box contains 100 gelatin-coated capsules for oral use. The label shows the NDC 0469-0657-73 and indicates the manufacturer as Astellas Ireland Co., Ltd., with marketing by Astellas Pharma US, Inc. Storage instructions and barcodes are also visible.*

FDA Label Image

Image 26

Packaging label for Prograf (tacrolimus) injection 5 mg/1 mL, sterile solution in 10 (1 mL) ampules. The label states the product is for intravenous use only after dilution, with dosage information referenced on the package insert. Manufactured and marketed by Astellas Pharma US, Inc., the label includes the Astellas logo and barcode.*

FDA Label Image

Image 27

Packaging label for Prograf Granules 0.2 mg per unit-dose packet (tacrolimus for oral suspension) by Astellas Pharma US, Inc. The label includes dosage instructions, storage conditions, manufacturer details, a barcode, and states the package contains 50 unit-dose packets.*

FDA Label Image

Image 28

Packaging label for Prograf Granules, tacrolimus for oral suspension, 1 mg per unit-dose packet. The label shows storage instructions, manufacturer details (Astellas Pharma Tech Co., LTD. and Astellas Pharma US, Inc.), and that the package contains 50 unit-dose packets. The label includes regulatory information, barcode, and usage instructions to mix granules with water only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.